Clover Biopharmaceuticals, Ltd. Transaction

Convertible Investment New Security Issue in China, Asia

Transaction Details

Name:Clover Biopharmaceuticals, Ltd.
Amount:Available on swfi.com
Announced At:02/23/2021
Closed At:02/23/2021
RegionAsia
Country:China
Type:New Security Issue
Security Type:Convertible Preferred Stock
Investment Type:Convertible
SectorHealthcare
Industry:Biotechnology
Summary:Available

Buyers

Entity 1
Asset Manager in Hong Kong		Stake
Available on swfi.com